Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan.

MLA

Yokomizo, Akira, et al. “Real-World Use of Enzalutamide in Men with Nonmetastatic Castration-Resistant Prostate Cancer in Japan.” International Journal of Clinical Oncology, vol. 27, no. 2, Feb. 2022, pp. 418–26. EBSCOhost, https://doi.org/10.1007/s10147-021-02070-z.

APA

Yokomizo, A., Yonese, J., Egawa, S., Fukuhara, H., Uemura, H., Nishimura, K., Nagata, M., Saito, A., Lee, T., Yamaguchi, S., & Nonomura, N. (2022). Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan. International Journal of Clinical Oncology, 27(2), 418–426. https://doi.org/10.1007/s10147-021-02070-z

Chicago

Yokomizo, Akira, Junji Yonese, Shin Egawa, Hiroshi Fukuhara, Hiroji Uemura, Kazuo Nishimura, Masayoshi Nagata, et al. 2022. “Real-World Use of Enzalutamide in Men with Nonmetastatic Castration-Resistant Prostate Cancer in Japan.” International Journal of Clinical Oncology 27 (2): 418–26. doi:10.1007/s10147-021-02070-z.